piracetam has been researched along with Atrophy in 4 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a patient with cerebellar ataxia of degenerative nature who was administered high-dose piracetam in a single-blind trial." | 9.10 | High-dose piracetam is effective on cerebellar ataxia in patient with cerebellar cortical atrophy. ( Altinel, A; Apaydin, H; Ozekmekçi, S; Vural, M, 2003) |
| "We describe a patient with cerebellar ataxia of degenerative nature who was administered high-dose piracetam in a single-blind trial." | 5.10 | High-dose piracetam is effective on cerebellar ataxia in patient with cerebellar cortical atrophy. ( Altinel, A; Apaydin, H; Ozekmekçi, S; Vural, M, 2003) |
| "Levetiracetam (LEV) treatment was started in combination with VPA in a patient with typical clinical, histological, and biochemical features of MERRF due to a mutation on the tRNA of Phenilalanine gene." | 1.33 | Antimyoclonic effect of levetiracetam in MERRF syndrome. ( Filosto, M; Galli, R; Mancuso, M; Murri, L; Pizzanelli, C; Siciliano, G, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, Y | 1 |
| Zhang, N | 1 |
| Liu, C | 1 |
| Shi, M | 1 |
| Sun, L | 1 |
| Abourazzak, S | 1 |
| Chaouki, S | 1 |
| Boubou, M | 1 |
| Amrani, M | 1 |
| Atmani, S | 1 |
| Hida, M | 1 |
| Vural, M | 1 |
| Ozekmekçi, S | 1 |
| Apaydin, H | 1 |
| Altinel, A | 1 |
| Mancuso, M | 1 |
| Galli, R | 1 |
| Pizzanelli, C | 1 |
| Filosto, M | 1 |
| Siciliano, G | 1 |
| Murri, L | 1 |
1 trial available for piracetam and Atrophy
| Article | Year |
|---|---|
High-dose piracetam is effective on cerebellar ataxia in patient with cerebellar cortical atrophy.
Topics: Adult; Atrophy; Cerebellar Ataxia; Cerebellar Cortex; Dose-Response Relationship, Drug; Female; Huma | 2003 |
3 other studies available for piracetam and Atrophy
| Article | Year |
|---|---|
Occipital epilepsy versus progressive myoclonic epilepsy in a patient with continuous occipital spikes and photosensitivity in electroencephalogram: A case report.
Topics: Anticonvulsants; Atrophy; Cerebral Cortex; Diagnosis, Differential; Disease Progression; Electroence | 2018 |
[Involuntary movements in infantile cobalamin deficiency appearing during treatment].
Topics: Anemia, Megaloblastic; Atrophy; Brain; Consanguinity; Electroencephalography; Female; Humans; Hydrox | 2013 |
Antimyoclonic effect of levetiracetam in MERRF syndrome.
Topics: Activities of Daily Living; Anticonvulsants; Atrophy; Brain; Drug Therapy, Combination; Female; Gene | 2006 |